Role of nitric oxide in cell adhesion and locomotion

Experimental Nephrology

Volumn 4, Issue 6, 1996, Pages 314-321

  Goligorsky, Michael S ^a   Noiri, Eisei ^a   Peresleni, Tatyana ^a   Hu, Yu ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Angiogenesis; Bone resorption; Cell migration; Epithelial wound healing; Integrins; Platelet aggregation

Indexed keywords

ARGININE; INTEGRIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANGIOGENESIS; CELL ADHESION; CELL MIGRATION; CELL MOTION; HUMAN; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; WOUND HEALING;

ANIMALS; BONE RESORPTION; CELL ADHESION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; EPITHELIUM; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; NITRIC OXIDE; PLATELET AGGREGATION; WOUND HEALING;

EID: 0029732812     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. 1-Integrin-dependent and independent polymerization of fibronectin. J Cell Biol 1996;132:227-238.
2. Lewis M, Fine LG, Norman JT: Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells. Kidney Int 1996;49:48-58.
3. Noiri E, Gailit J, Sheth D, Magazine H, Gurrath M, Muller G, Kessler H, Goligorsky MS: Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int 1994;46: 1050-1058.
4. Lane TF, Sage H: The biology of SPARC, a protein that modulates cell-matric interactions. FASEB J 1994;8:163-173.
5. Edelman GM, Crossin KL: Cell adhesion molecules: Implication for molecular histology. Annu Rev Biochem 1991;60:155-190.
6. Peskin C, Odell G, Oster G: Cellular motions and thermal fluctuations: The Brownian ratchet. Biophys J 1993;65:316-324.
7. Giaever I, Keese CR: Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci USA 1991;88:7896-7900.
8. Ziehe M, Morbidelli L, Donnini S: Angiogenesis. Exp Nephrol 1996;4:1-14.
9. Kartha S, Toback GF: Migration of kidney epithelial cells during recovery from acute renal failure; in Goligorsky MS, Stein JH (eds): Acute Renal Failure: New Concepts and Therapeutic Strategies. New York, Churchill Livingstone, 1995, pp 287-319.
10. Schmidt CE, Horwitz AF, Lauffenburger DA, Sheetz MP: Integrin-cytoskeletal interactions in migrating fibroblasts are dynamic, asymmetric, and regulated. J Cell Biol 1993;123:977-991.
11. Singer SJ, Kupfer A: The directed migration of eukaryotic cells. Annu Rev Cell Biol 1986;2: 337-365.
12. Post P, DeBiasio R, Taylor DL: A fluorescent protein biosensor of myosin II regulatory light chain phosphorylation reports a gradient of phosphorylated myosin II in migrating cells. Mol Biol Cell 1995;6:1755-1768.
13. Condeelis J: Life at the leading edge: The formation of cell protrusions. Annu Rev Cell Biol 1993;9:411-444.
14. Brundage R, Fogarty K, Tuft R, Fay FS: Chemotaxis of newt eosinophils: Calcium regulation of chemotactic response. Am J Physiol 1993;265:C1527-C1543.
15. Hendey B, Klee CB, Maxfield FR: Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. Science 1992;258:296-299.
16. Schwab A, Wojnowski L, Kerstin G, Oberleitner H: Oscillating activity of a Ca-sensitive K channel: A prerequisite for migration of transformed Madin-Darby canine kidney focus cells. J Clin Invest 1994;93:1631-1636.
17. Marks P, Hendey B, Maxfield FR: Attachment to fibronectin of vitronectin makes human neutrophil migration sensitive to alterations in cytosolic free calcium concentration. J Cell Biol 1991;112:149-158.
18. Noiri E, Peresleni T, Srivastava N, Weber P, Bahou WF, Peunova N, Goligorsky MS: Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am J Physiol 1996;270:C794-C802.
19. Ruth P, Wang G, Boekhoff I, May B, Pfeifer A, Penner R, Korth M, Breer H, Hofmann F: Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol-1,4,5-triphosphate production. Proc Natl Acad Sci USA 1993;90:2623-2627.
20. Hall CL, Wang C, Lange LA, Turley EA: Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 1994;126: 575-588.
21. Hendey B, Klee CB, Maxfield FR: Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. Science 1992;258:296-299.
22. 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res 1992;200: 272-284.
23. 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993; 121:163-170.
24. Gamble J, Matthias L, Meyer G, Kaur P, Russ G, Fault R, Berndt M, Vadas MA: Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol 1993;121:931-943.
25. Friedlander M, Brooks P, Shaffer R, Kincaid C, Varner J, Cheresh DA: Definition of two angiogenic pathways by distinct αV integrins. Science 1995;270:1500-1502.
26. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T, Aizawa S: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995;377:539-544.
27. Noiri E, Testa J, Quigley J, Colfresh D, Keese C, Giaever I, Goligorsky MS: Nitric oxide-driven podokinesis is a prerequisite for endothelial cell migration and angiogenesis: Scalar vs vectrial locomotion, submitted.
28. Ruoslahti E, Noble NA, Kagami S, Border WA: Integrins. Kidney Int 1994;45(suppl 44):17-22.
29. Stamler JS: Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-936.
30. Klemke R, Yebra M, Bayna E, Cheresh DA: Receptor tyrosine kinase signaling required for integrin αVβ5-directed cell motility but not adhesion on vitronectin. J Cell Biol 1994;127: 859-866.
31. Plopper G, McNamee H, Dike L, Bojanowski K, Ingber DE: Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 1995;6:1349-1365.
32. Miyamoto S, Teramoto H, Coso O, Gutkind S, Burbelo P, Akiyama S, Yamada KM: Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995;131: 791-805.
33. Maher PA: Activation of phosphotyrosine phosphatase activity by reduction of cell-substrate adhesion. Proc Natl Acad Sci USA 1993; 90:11177-11181.
34. Caselli A, Camici G, Manao G, Moneti G, Pazzagli L, Cappugi G, Ramponi G: Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J Biol Chem 1994;269:24878-24882.
35. Kartha S, Toback FG: Adenine nucleotides stimulate migration in wounded cultures of kidney epithelial cells. J Clin Invest 1992;90: 288-292.
36. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
37. Niu X, Smith CW, Kubes P: Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994;74:1133-1140.
38. 2 integrin function following acute carbon monoxide poisoning. Tox Appl Pharm 1994;128:105-110.
39. De Caterina R, Libby P, Peng H, Thannickal V, Rajavashisth T, Gimbrone M, Shin W, Liao J: Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest 1995;96:60-68.
40. Beauvais F, Michel L, Dubertret L: Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro. J Cell Physiol 1995;165:610-614.
41. Reyes A, Porras B, Chasalow F, Klahr S: L-Arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 1994;45:1346-1354.
42. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE: Production of angiogenic activity by human monocytes requires an L-arginine/ nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 1994;91:4190-4194.
43. Ziche M, Morbidelli L, Masini E, Amerini S, Granger H, Maggi C, Geppetti P, Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94:2036-2040.
44. Cooke J, Tsao P: Is NO an endogenous anti-atherogenic molecule; Arterioscler Thromb 1994;14:653-655.
45. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM: Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-1596.
46. Ramsey MW, Goodfellow J, Jones CJ, Luddington LA, Lewis MJ, Henderson AH: Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995;92:3212-3219.
47. Lefer AM, Ma X: Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb 1993;13:771-776.
48. Flavahan NA: Atheroclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF/ nitric oxide activity. Circulation 1992;85; 1927-1938.
49. Lefer AM, Tsao P, Lefer DJ, Ma X: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991;5:2029-2034.
50. Radomski MW, Palmer R, Moncada S, Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; ii:1057-1058.
51. Ma X, Weyrich A, Lefer DJ, Lefer AM: Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-412.
52. May GR, Crook P, Moore P, Page CP: The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol 1991;102:759-763.
53. Liao J, Shin W, Lee W, Clark S: Oxidized LDL decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995;270:319-324.
54. Von der Leyen H, Gibbons G, Morishita R, Lewis N, Zhang L, Nakajima M, Kaneda Y, Cooke J, Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995;92:1137-1141.
55. Jenkins D, Charles I, Thomsen L, Moss D, Holmes L, Baylis S, Rhodes P, Westmore K, Emson P, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92:4392-4396.
56. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
57. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31.
58. Dubey R, Jackson E, Luscher RF: Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cells. J Clin Invest 1995; 96:141-149.
59. Grag UC, Hassid A: Nitric oxide-generating vasodilator and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-1777.
60. Marks D, Vita J, Folts J, Keaney J, Welch G, Loscalso J: Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 1995;96:2603-2638.
61. Radomski M, Palmer R, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.
62. Radomski M, Palmer R, Moncada S: Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. Trends Pharmacol Sci 1991;12:87-88.
63. Malinski T, Radomski M, Taha Z, Moncada S: Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun 1993;194:960-965.
64. Loscalzo J: Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol 1992;70: 18B-22B.
65. Westberg G, Shultz P, Raij L: Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis. Kidney Int 1994;46:711-716.
66. Wallace J, McKnight W, Del Soldato P, Baydoun A, Cirino G: Antithrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest 1995;96:2711-2718.
67. Blair H, Teitelbaum S, Ghiselli R, Gluck S: Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989;245:855-857.
68. McIntyre I, Zaidi M, Alam A, Datta H, Moonga B, Lidbury P, Hecker M, Vane JR: Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 1991;88:2936-2940.
69. Kasten T, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko T, Settle S, Currie M, Nickols GA: Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 1994;91: 3569-3573.
70. Brandi M, Hukkanen M, Umeda T, Morandi-Bidhendi N, Bianchi S, Gross SS, Polak JM, MacIntyre I: Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 1995;92:2954-2958.
71. Pitsillides A, Rawlinson S, Suswillo R, Bourrin S, Zaman G, Lanyon L: Mechanical strain-induced NO production by bone cells: A possible role in adaptive bone (re)modeling. FASEB J 1995;9:1614-1622.